Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Kunzea oil versus amorolfine for toenail onychomycosis
ACTRN12614000946617Phase 2Completed
- Sponsor
- University of Tasmania
- Start
- Aug 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of amorolfine in onychomycosis (2 arms), sponsored by University of Tasmania. Primary endpoint: Mycological cure. Started Aug 2007; status: completed.
02
Drugs
amorolfine
03
Conditions
onychomycosis
Beyond the preview
Go deeper on ACTRN12614000946617.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12614000946617.